No. 329-Canadian Contraception Consensus Part 4 of 4 Chapter 9: Combined Hormonal Contraception - Black, Amanda; Guilbert, Edith; Costescu, Dustin; Dunn, Sheila; Fisher, William; Kives, Sari; Mirosh, Melissa; Norman, Wendy V.; Pymar, Helen; Reid, Robert; Roy, Geneviève; Varto, Hannah; et al. (Journal of obstetrics and gynaecology Canada, 2017)
Keywords: Body Mass Index; Canada; combined hormonal contraception; continuous hormonal contraception; Contraception; Contraceptives, Oral, Combined - administration & dosage; Contraceptives, Oral, Combined - adverse effects; Contraceptives, Oral, Combined - pharmacokinetics; Contraceptives, Oral, Combined - pharmacology; Contraceptives, Oral, Hormonal - administration & dosage; Contraceptives, Oral, Hormonal - adverse effects; Contraceptives, Oral, Hormonal - pharmacokinetics; Contraceptives, Oral, Hormonal - pharmacology; Contraindications, Drug; emergency contraception; family planning; Female; hormonal contraception; Humans; Medication Adherence; Menstruation Disturbances - chemically induced; Myocardial Infarction - chemically induced; Neoplasms - chemically induced; Neoplasms - prevention & control; Obstetrics and Gynecology; oral contraceptive pill; Patient Education as Topic; Pregnancy; Risk Factors; sexual health; Stroke - chemically induced; transdermal contraceptive patch; vaginal contraceptive ring; Venous Thromboembolism - chemically induced; Canada; CDC; DVT; LNG; Cu-IUD; UPA; STI; HFI; E2; transdermal contraceptive patch; UPI; IUC; IUD; MI; EC; SOGC; WHO; AED; EE; sexual health; IUS; Contraception; POP; Canada; emergency contraception; ENG; combined hormonal contraception; RCT; ART; VTE; CYP3A4; FPV; HPV; hormonal contraception; family planning; HDL; vaginal contraceptive ring; COC; oral contraceptive pill; BMI; WY; E2V; continuous hormonal contraception; HIV; PE; C/E; PI; PK; SHBG; CHC; 17 beta-estradiol; progestin-only pill; sexually transmitted infection; high-density lipoprotein; myocardial infarction; Pearl Index (the number of contraceptive failures per 100 women-years of use); cytochrome P450-3A4; World Health Organization; ethinyl estradiol; body mass index; combined oral contraceptive pill; copper intrauterine device; levonorgestrel; fosamprenavir; sex hormone binding globulin; human papillomavirus